North America RNAi Therapeutics Market Trends, Size, Segment and Growth by Forecast to 2030

 

Market Overview and Dynamics

The North America RNAi therapeutics market is projected to grow from US 302.77 million in 2019 to US 302.77 million in 2019 to US 598.60 million by 2027, expanding at a compound annual growth rate (CAGR) of 9.0% during the forecast period. Key factors driving this growth include increasing investments in RNAi therapies and the rising prevalence of infectious diseases and chronic conditions. However, the market's expansion may face challenges due to the high cost associated with RNAi therapy development, which could hinder growth to some extent over the coming years.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐๐ƒ๐… ๐๐ซ๐จ๐œ๐ก๐ฎ๐ซ๐ž - https://www.businessmarketinsights.com/sample/TIPRE00015136

Key Market Segments

In terms of molecule type, the small interfering RNAs (siRNA) segment accounted for the largest share of the North America RNAi therapeuticsmarket in 2019.In terms of route of administration, the pulmonary delivery segment accounted for the largest share of the North America RNAi therapeuticsmarket in 2019.In terms of application, oncology segment accounted for the largest share of the North America RNAi therapeuticsmarket in 2019.In terms of end user, research and academic laboratoriessegment accounted for the largest share of the North America RNAi therapeutics market in 2019

Major Sources and Companies Listed

Several major primary and secondary sources associated with the North America RNAi therapeuticsmarket report are theWorld Health Organization (WHO), National Cancer Institute (NCI),Centers of Disease Control and Prevention (CDC),Asthma and Allergy Foundation of America,American Lung Association,the American Cancer Society (ACS), and others.

North America RNAi Therapeutics Strategic Insights

Strategic insights for the North America RNAi Therapeutics provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America RNAi Therapeutics Report Scope

Attribute

Details

 

Market Size (2019)

US$ 302.77 Million

 

Market Size (2027)

US$ 598.60 Million

 

CAGR (2019-2027)

9.0%

 

Historical Data

2017-2018

 

Forecast Period

2020-2027

 

Segments Covered

Molecule Type, Application, Route of Administration, End User

 

Molecule Types

Small Interfering RNAs, MicroRNA

 

Applications

Genetic Disorders, Oncology, Neurodegenerative Disorders, Cardiovascular, Respiratory Disorders, Infectious Diseases, Renal Diseases

 

Routes of Administration

Intradermal, Pulmonary, Intravenous, Intraperitoneal

 

End Users

Diagnostic Labs, Research Labs, Hospitals

 

Regions Covered

North America (US, Canada, Mexico)

 

Key Companies

Alnylam, Arrowhead, Quark, Rexahn, Arbutus

North America RNAi Therapeutics Regional Insights

The geographic scope of the North America RNAi Therapeutics refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Reasons to buy report

  • It provides understanding of the North America, RNAi therapeuticsmarket landscape and identifies RNAi therapeuticsmarket segments that are most likely to guarantee a strong return.
  • It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the North America RNAi therapeuticsmarket.
  • It helps efficiently plan merger and acquisition, and partnership deals in the RNAi therapeuticsmarket by identifying market segments with the most promising probable sales
  • It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis ofRNAi therapeuticsmarket performance of various segments pertaining to the North America RNAi therapeuticsmarket.
  • It providesRNAi therapeuticsmarket revenue forecast of the market based on various segments for the period from 2019 to 2027.


NORTH AMERICA RNAI THERAPEUTICSMARKET SEGMENTATION

Category

Subcategories

 

Molecule Type

siRNA, miRNA

 

Route of Administration

Pulmonary, Intravenous, Intradermal, Intraperitoneal, Others

 

Application

Oncology, Cardiovascular, Respiratory, Renal, Genetic, Neurodegenerative, Infectious, Others

 

End User

Research Labs, Hospitals, Diagnostic Labs

 

Country

US, Canada, Mexico

 

Company Profiles

Alnylam, Arrowhead, Quark, Rexahn, Arbutus

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Dรฉfense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

Author’s Bio
Akshay
Senior Market Research Expert at Business Market Insights

Comments

Post a Comment

Popular posts from this blog

Europe Poultry Feed Market Trends, Size, Segment and Growth by Forecast to 2030

  The poultry feed market in Europe is expected to grow from US$ 26,168.26 million in 2021 to US$ 31,874.91 million by 2028; it is estimated to grow at a CAGR of 2.9% from 2021 to 2028. Download Full PDF Sample Copy of Market Report @- https://www.businessmarketinsights.com/sample/TIPRE00026749  The poultry sector is registering a continual rise across the region. An increase in poultry production is mainly attributed to the rising demand for poultry meat and eggs. Poultry is regarded as one of the most cost-effective protein sources due to which the demand for poultry products, such as eggs and meat, continues to rise. There is a surge in chicken consumption among people who are more concerned about their health. The increasing youth population is expected to lead to an increase in poultry production and consumption with their modern consumption habits. As per the FAO, poultry meat represented about 39% of global meat production in 2019. Global egg production h...
Read more

North America Meat Extract Market Trends, Size, Segment and Growth by Forecast to 2030

  The North America meat extract market is on a steady growth trajectory, projected to rise from US$ 570.67 million in 2021 to US$ 795.62 million by 2028 , reflecting a CAGR of 4.9% . ๐ƒ ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐๐ƒ๐… ๐๐ซ๐จ๐œ๐ก๐ฎ๐ซ๐ž - https://www.businessmarketinsights.com/sample/BMIRE00025889 Key Growth Drivers: Rising Meat Consumption: With a growing global population and an expanding middle class, the demand for protein-rich, affordable food options is increasing. Popularity of Poultry: Poultry is gaining traction as a healthier and cost-effective protein source, leading to greater demand for poultry-based meat extracts. Flavor Enhancement Trend: As consumers seek healthier lifestyles without compromising on taste, food manufacturers are leveraging meat extracts to enhance flavors in ready-to-eat meals, soups, sauces, and snacks . Natural Alternative: Meat extracts are emerging as a healthier substitute for s...
Read more

Benelux Heavy Construction Equipment Market Trends, Size, Segment and Growth by Forecast to 2030

  The BENELUX Heavy Construction Equipment market was worth US$ 3.70 billion in 2024 and is projected to reach US$ 6.20 billion by 2031; it is expected to register a CAGR of 7.70% from 2025 to 2031. Executive Summary and BENELUX Heavy Construction Equipment Market Analysis: The growth of the heavy construction equipment market in Belgium is attributed to ongoing infrastructure projects and development in various industrial sectors. In addition, the rising government investment in infrastructure development has contributed to the market growth. For instance, in June 2022, the European Commission funded the Belgium government with US$ 125.37 million for six transport infrastructure projects in the country. This funding aimed to strengthen and modernize the European transport network. Also, in 2023, the construction sector investment was valued at ~US$ 73.07 billion. According to the data published by the European Federation in 2023, the construction industry witnessed contracted...
Read more